Search results
BMS and Zai Lab’s Augtyro gains NMPA approval to treat NSCLC
Pharmaceutical Technology· 5 days agoAugtyro, an orally administered tyrosine kinase inhibitor (TKI) designed to inhibit specific kinases...
ITR filing FY2024: What tax benefits do senior citizens receive on medical insurance
Business Today· 2 hours agoConsidering the substantial medical expenses prevalent today, a comprehensive health insurance...
Water troughs kept ready at veterinary institutions for livestock brought for treatment
The Hindu· 6 days agoThe move comes in the wake of heatwave prevailing for the last one month and as per the direction of...
6 key questions to ask your doctor about Chronic Myeloid Leukemia - Times of India
The Times of India· 2 days agoChronic myeloid leukemia, or CML, is a type of cancer that originates in the blood-forming cells of...
Amy Winehouse’s Talent and Tragedies Are on Full Display in Her Biopic ‘Back to Black’
Biography· 20 hours agoAmy Winehouse was known for her Grammy-winning album ‘Back to Black’ and the songs ‘Rehab’ and...
Water Intoxication: What Happens When You Drink Too Much Water?
Verywell Health· 5 days agoSigns and symptoms can be vague but may include clear or colorless urine, headache, nausea and...
Uniquity Bio launches to focus on immunology and inflammation
Pharmaceutical Technology· 2 days agoBio plans to initiate Phase II clinical trials of the product for chronic obstructive pulmonary ...
Chronic auto-immune disease often diagnosed late as symptoms it presents are non-specific: Experts
The Telegraph· 5 days agoA chronic auto-immune disease is often diagnosed late because the symptoms it presents are non-specific, experts said at a seminar on Sunday. The seminar was an attempt to ...
Childhood and midlife stress could increase risk of developing Alzheimer’s
Scroll· 19 hours agoStressful life events, such as the death of a loved one or divorce, put a person at greater risk of developing dementia in later life, a recent study has found. The study, published in Annals ...
Biogen, Ionis to discontinue development of experimental ALS drug - ET HealthWorld | Pharma
The Economic Times· 1 day agoShares of Biogen and Ionis were each down nearly 2 per cent in premarket trading. This marks another...